Y
Yen Ying Lim
Researcher at Monash University, Clayton campus
Publications - 146
Citations - 5611
Yen Ying Lim is an academic researcher from Monash University, Clayton campus. The author has contributed to research in topics: Cognitive decline & Dementia. The author has an hindex of 39, co-authored 119 publications receiving 4034 citations. Previous affiliations of Yen Ying Lim include Florey Institute of Neuroscience and Mental Health & Rhode Island Hospital.
Papers
More filters
Journal ArticleDOI
Whitepaper: Defining and investigating cognitive reserve, brain reserve, and brain maintenance
Yaakov Stern,Eider M. Arenaza-Urquijo,David Bartrés-Faz,Sylvie Belleville,Marc Cantilon,Gaël Chételat,Michael Ewers,Nicolai Franzmeier,Gerd Kempermann,William S. Kremen,Ozioma C. Okonkwo,Nikolaos Scarmeas,Nikolaos Scarmeas,Anja Soldan,Chinedu T. Udeh-Momoh,Michael Valenzuela,Prashanthi Vemuri,Eero Vuoksimaa,Eider M. Arenaza Urquiljo,Marc Cantillon,Sean A. P. Clouston,Ainara Estanga,Brian T. Gold,Christian G. Habeck,Richard N. Jones,Renata Kochhann,W.S. Kremen,Yen Ying Lim,Pablo Martinez-Lage,Silvia Morbelli,Rik Ossenkoppele,Corinne Pettigrew,Allyson C. Rosen,Xiaowei Song,Anita C. van Loenhoud +34 more
TL;DR: The reserve, resilience, and protective factors professional interest area established a whitepaper workgroup to develop consensus definitions for cognitive reserve, brain reserve, and brain maintenance and evaluated measures that have been used to implement these concepts in research settings and developed guidelines for research that explores or utilizes these concepts.
Journal ArticleDOI
Predicting Alzheimer disease with β-amyloid imaging: Results from the Australian imaging, biomarkers, and lifestyle study of ageing
Christopher C. Rowe,Pierrick Bourgeat,Kathryn A. Ellis,Belinda M. Brown,Yen Ying Lim,Rachel S. Mulligan,Gareth Jones,Paul Maruff,Michael Woodward,Roger I. Price,Peter Robins,Henri Tochon-Danguy,Graeme O'Keefe,Kerryn E. Pike,Patsy Yates,Cassandra Szoeke,Olivier Salvado,S. Lance Macaulay,T.J. O'Meara,Richard Head,Lynne Cobiac,Greg Savage,Ralph N. Martins,Colin L. Masters,David Ames,Victor L. Villemagne +25 more
TL;DR: This work aimed to determine the prognostic value of β‐amyloid imaging, alone and in combination with memory performance, hippocampal atrophy, and apolipoprotein E ε4 status in nondemented, older individuals.
Journal ArticleDOI
Cerebral quantitative susceptibility mapping predicts amyloid-β-related cognitive decline.
Scott Ayton,Amir Fazlollahi,Amir Fazlollahi,Pierrick Bourgeat,Pierrick Bourgeat,Parnesh Raniga,Amanda Ng,Yen Ying Lim,Ibrahima Diouf,Ibrahima Diouf,Shawna Farquharson,Shawna Farquharson,Jurgen Fripp,Jurgen Fripp,David Ames,James D. Doecke,James D. Doecke,Patricia Desmond,Roger J. Ordidge,Colin L. Masters,Colin L. Masters,Christopher C. Rowe,Paul Maruff,Victor L. Villemagne,Olivier Salvado,Olivier Salvado,Ashley I. Bush,Ashley I. Bush +27 more
TL;DR: The large variance in cognitive deterioration in subjects who test positive for amyloid-β by positron emission tomography indicates that convergent pathologies, such as iron accumulation, might combine with amyloids-β to accelerate Alzheimer's disease progression.
Journal ArticleDOI
Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease
Yen Ying Lim,Paul Maruff,Robert H. Pietrzak,David Ames,Kathryn A. Ellis,Kathryn A. Ellis,Karra J. Harrington,Nicola T. Lautenschlager,Nicola T. Lautenschlager,Cassandra Szoeke,Ralph N. Martins,Colin L. Masters,Victor L. Villemagne,Victor L. Villemagne,Christopher C. Rowe +14 more
TL;DR: The combined detection of amyloid positivity and objectively-defined decline in memory are reliable indicators of early Alzheimer's disease, and the detection of decline in non-memory functions in amyloids-positive individuals with mild cognitive impairment may assist in determining the level of disease severity in these individuals.
Journal ArticleDOI
Amyloid-β, Anxiety, and Cognitive Decline in Preclinical Alzheimer Disease A Multicenter, Prospective Cohort Study
Robert H. Pietrzak,Robert H. Pietrzak,Yen Ying Lim,Yen Ying Lim,Alexander Neumeister,David Ames,David Ames,Kathryn A. Ellis,Kathryn A. Ellis,Kathryn A. Ellis,Karra Harrington,Nicola T. Lautenschlager,Nicola T. Lautenschlager,Carolina Restrepo,Ralph N. Martins,Colin L. Masters,Victor L. Villemagne,Victor L. Villemagne,Christopher C. Rowe,Paul Maruff +19 more
TL;DR: These results provide additional support for the deleterious effect of elevated Aβ levels on cognitive function in preclinical AD and suggest that elevated anxiety symptoms moderate the effect of Aβ on cognitive decline in pre clinical AD, resulting in more rapid decline in several cognitive domains.